Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria

Parasites and Vectors

Volumn 4, Issue 1, 2011, Pages

  Brieger, William R ^a   Okeibunor, Joseph C ^b   Abiose, Adenike O ^c   Wanji, Samuel ^d   Elhassan, Elizabeth ^e   Ndyomugyenyi, Richard ^f   Amazigo, Uche V ^g  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF NIGERIA   (Nigeria)

^c Sightcare International   (Nigeria)

^d Research Foundation in Tropical Diseases and Environment   (Cameroon)

^e Sight Savers   (Senegal)

^f National Onchocerciasis Control Programme   (Uganda)

^g African Programme for Onchocerciasis Control   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; ANTIPARASITIC AGENT;

ADULT; ARTICLE; BIVARIATE ANALYSIS; CAMEROON; CHILD; CORRELATIONAL STUDY; ETHNIC GROUP; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NIGERIA; ONCHOCERCIASIS; OVERALL SURVIVAL; PATIENT COMPLIANCE; PATIENT EDUCATION; SCHOOL CHILD; SOCIAL BEHAVIOR; ADOLESCENT; AGED; MIDDLE AGED; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPARASITIC AGENTS; CAMEROON; CHILD; FEMALE; HUMANS; INTERVIEWS AS TOPIC; IVERMECTIN; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NIGERIA; ONCHOCERCIASIS; YOUNG ADULT;

EID: 79960660872     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-4-152     Document Type: Article

References (20)

1. The future of onchocerciasis control in Africa. Amazigo U, Boatin B, The Lancet 2006 368 1946 1947 10.1016/S0140-6736(06)69786-9 (Pubitemid 44821367)
2. Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control programme in West Africa. Plaisier AP, Alley ES, van Oortmarssen GJ, Boatin BA, Habbema JDF, Bulletin of the World Health Organization 1997 75 3 237 245 9277011 (Pubitemid 27373563)
3. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Borsboom GJ, Boatin BA, Nagelkerke NJ, Agoua H, Akpoboua KL, Alley EW, Bissan Y, Renz A, Yameogo L, Remme JH, Habbema JD, Filaria J 2003 2 1 8 10.1186/1475-2883-2-8 12769825 (Pubitemid 38751363)
4. Impact of ivermectin on illness and disability associated with onchocerciasis. Tielsch JM, Beeche A, Trop Med Int Health 2004 9 4 45 A56 10.1111/j.1365-3156.2004.01213.x 15078278 (Pubitemid 38582243)
5. Performance versus predictors: Evaluating sustainability in community-directed treatment projects of the African Programme for Onchocerciasis Control. Amazigo U, Okeibunor JC, Matovu V, Zouré H, Bump J, Seketeli A, Soc Sci Med 2007 64 2007 2070 2082 17383061 (Pubitemid 46582824)
6. Year 2004 progress report of WHO/APOC. APOC, http://www.apoc.bf/en/ download.htm accessed 21 May 2007
7. IPSOR Medication Compliance and Persistence Special Interest Group: Standardizing definition of terms. International Society for Pharmacoeconomics and Outcomes Research 2005 http://www.ispor.org/sigs/MCP-accomplishments.asp accessed 15 March 2006
8. Report of the 20th session of the Technical Consultative Committee (TCC)- Ouagadougou. APOC, 2005 http://www.apoc.bf/en/download.htm accessed 21 May 2007
9. Can ivermectin mass treatments eliminate onchocerciasis in Africa? Winnen M, Plaisier AP, Alley ES, Nagelkerke NJD, van Oortmarssen G, Boatin BA, Habbema JDF, Bulletin of the World Health Organization 2002 80 384 390 12077614 (Pubitemid 34578791)
10. Factors associated with coverage in community directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria. Brieger WR, Otusanya SA, Oke GA, Oshiname FO, Adeniyi JD, Trop Med and Int Health 2002 7 1 11 18 10.1046/j.1365-3156.2002.00826.x (Pubitemid 34131806)
11. Missed treatment opportunities, for pregnant and breast-feeding women, in onchocerciasis mass-treatment programmes in south-eastern Nigeria. Maduka CU, Nweke LN, Miri ES, Amazigo U, Emukah EC, Richards FO, Ann Trop Med & Parasitol 2004 98 7 697 702 10.1179/000349804225021497 21422215 (Pubitemid 39390073)
12. Refusal to take ivermectin: the associated 'risk' factors in Hoima district, Uganda. Semiyaga NB, Lalobo O, Ndyomugyenyi R, Ann Trop Med & Parasitol 2005 99 2 165 172 10.1179/136485905X24201 21422215 (Pubitemid 40393044)
13. Non-adherence to community directed treatment with ivermectin for onchocerciasis control in Rungwe district, southwest Tanzania. Lakwo TL, Gasarasi DB, East Afr Med J 2006 83 6 326 32 16989378 (Pubitemid 44358315)
14. Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia. Yirga D, Deribe K, Woldemichael K, Wondafrash M, Kassahun W, Parasit Vectors 2010 3 48 10.1186/1756-3305-3-48 20525182
15. Onchocerciasis Control: Vision for the Future from a Ghanian perspective. Taylor MJ, Awadzi K, Basá̃ez MG, Biritwum N, Boakye D, Boatin B, Bockarie M, Churcher TS, Debrah A, Edwards G, Hoerauf A, Mand S, Matthews G, Osei-Atweneboana M, Prichard RK, Wanji S, Adjei O, Parasit Vectors 2009 2 7 10.1186/1756-3305-2-7 19154624
16. Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia. Bhullar N, Maikere J, Parasit Vectors 2010 3 70 10.1186/1756-3305-3-70 20701744
17. Predictors of compliance with community-directed ivermectin treatment in Uganda: quantitative results. Nuwaha F, Okware J, Ndyomugyenyi R, Trop Med Int Health 2005 10 7 659 67 10.1111/j.1365-3156.2005.01436.x 15960704 (Pubitemid 40933939)
18. Community-perceived benefits of ivermectin treatment in northeastern Nigeria. Akogun OB, Akogun MK, Audu Z, Soc Sci Med 2000 50 10 1451 6 10.1016/S0277-9536(99)00336-6 10741580 (Pubitemid 30100882)
19. Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort. Yuan Y, L'italien G, Mukherjee J, Iloeje U, HIV Med 2006 7 3 156 62 10.1111/j.1468-1293.2006.00355.x 16494629 (Pubitemid 43337594)
20. Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Iliyasu Z, Kabir M, Abubakar IS, Babashani M, Zubair ZA, Niger J Med 2005 14 3 290 4 16350700